Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Melatonin and ulcerative colitis: evidence, biological mechanisms, and future research.

Terry PD, Villinger F, Bubenik GA, Sitaraman SV.

Inflamm Bowel Dis. 2009 Jan;15(1):134-40. doi: 10.1002/ibd.20527. Review.

PMID:
18626968
2.
3.

A review of the use of melatonin in ulcerative colitis: experimental evidence and new approaches.

Jena G, Trivedi PP.

Inflamm Bowel Dis. 2014 Mar;20(3):553-63. doi: 10.1097/01.MIB.0000436962.32164.6e. Review.

PMID:
24247651
4.

Murine models of ulcerative colitis.

Flynn C, Levine J, Rosenberg DW.

Arch Pharm Res. 2003 Jun;26(6):433-40. Review.

PMID:
12877549
5.

Drug treatment of ulcerative colitis: unfractionated heparin, low molecular weight heparins and beyond.

Malhotra S, Bhasin D, Shafiq N, Pandhi P.

Expert Opin Pharmacother. 2004 Feb;5(2):329-34. Review.

PMID:
14996629
6.

Current pharmacologic therapies and emerging alternatives in the treatment of ulcerative colitis.

Nakamura T, Nagahori M, Kanai T, Watanabe M.

Digestion. 2008;77 Suppl 1:36-41. doi: 10.1159/000111486. Epub 2008 Jan 18. Review.

7.

Hypothesis about mechanisms through which nicotine might exert its effect on the interdependence of inflammation and gut barrier function in ulcerative colitis.

McGilligan VE, Wallace JM, Heavey PM, Ridley DL, Rowland IR.

Inflamm Bowel Dis. 2007 Jan;13(1):108-15. Review.

PMID:
17206646
8.

Melatonin and serotonin effects on gastrointestinal motility.

Thor PJ, Krolczyk G, Gil K, Zurowski D, Nowak L.

J Physiol Pharmacol. 2007 Dec;58 Suppl 6:97-103. Review.

9.

Cytokines in the cotton top tamarin model of human ulcerative colitis.

Warren BF.

Aliment Pharmacol Ther. 1996;10 Suppl 2:45-7; discussion 48. Review.

PMID:
8899100
10.

Melatonin in cancer management: progress and promise.

Jung B, Ahmad N.

Cancer Res. 2006 Oct 15;66(20):9789-93. Review.

11.

Review article: new drug formulations, chemical entities and therapeutic approaches for the management of ulcerative colitis.

Ng SC, Kamm MA.

Aliment Pharmacol Ther. 2008 Oct 1;28(7):815-29. doi: 10.1111/j.1365-2036.2008.03800.x. Review.

12.

Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares.

Higgins PD, Rubin DT, Kaulback K, Schoenfield PS, Kane SV.

Aliment Pharmacol Ther. 2009 Feb 1;29(3):247-57. doi: 10.1111/j.1365-2036.2008.03865.x. Epub 2008 Oct 7. Review.

13.

Balsalazide disodium for the treatment of ulcerative colitis.

Patil SA, Moss AC.

Expert Rev Gastroenterol Hepatol. 2008 Apr;2(2):177-84. doi: 10.1586/17474124.2.2.177. Review.

PMID:
19072352
14.

Ulcerative colitis: current medical therapy and strategies for improving medication adherence.

Zhang Z, Kennedy H.

Eur J Gastroenterol Hepatol. 2009 Jan;21(1):1-8. doi: 10.1097/MEG.0b013e32830bfb88. Review.

PMID:
19011573
15.

Therapeutic strategies for the management of ulcerative colitis.

Ng SC, Kamm MA.

Inflamm Bowel Dis. 2009 Jun;15(6):935-50. doi: 10.1002/ibd.20797. Review.

PMID:
18985710
16.

Curcumin has bright prospects for the treatment of inflammatory bowel disease.

Hanai H, Sugimoto K.

Curr Pharm Des. 2009;15(18):2087-94. Review.

PMID:
19519446
17.

A meta-analysis of the efficacy of sulfasalazine in comparison with 5-aminosalicylates in the induction of improvement and maintenance of remission in patients with ulcerative colitis.

Nikfar S, Rahimi R, Rezaie A, Abdollahi M.

Dig Dis Sci. 2009 Jun;54(6):1157-70. doi: 10.1007/s10620-008-0481-x. Epub 2008 Sep 4. Review.

PMID:
18770034
18.

Balsalazide: a novel 5-aminosalicylate prodrug for the treatment of active ulcerative colitis.

Wiggins JB, Rajapakse R.

Expert Opin Drug Metab Toxicol. 2009 Oct;5(10):1279-84. doi: 10.1517/17425250903206996. Review.

PMID:
19743890
19.

Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.

Bourreille A, Ignjatovic A, Aabakken L, Loftus EV Jr, Eliakim R, Pennazio M, Bouhnik Y, Seidman E, Keuchel M, Albert JG, Ardizzone S, Bar-Meir S, Bisschops R, Despott EJ, Fortun PF, Heuschkel R, Kammermeier J, Leighton JA, Mantzaris GJ, Moussata D, Lo S, Paulsen V, Panés J, Radford-Smith G, Reinisch W, Rondonotti E, Sanders DS, Swoger JM, Yamamoto H, Travis S, Colombel JF, Van Gossum A; World Organisation of Digestive Endoscopy (OMED) and the European Crohn's and Colitis Organisation (ECCO).

Endoscopy. 2009 Jul;41(7):618-37. doi: 10.1055/s-0029-1214790. Epub 2009 Jul 8. Review.

PMID:
19588292
20.

Melatonin.

Piccirillo JF.

Prog Brain Res. 2007;166:331-3. Review.

PMID:
17956796

Supplemental Content

Support Center